Cargando…
New Antifungal Agents with Azole Moieties
Fungal conditions affect a multitude of people worldwide, leading to increased hospitalization and mortality rates, and the need for novel antifungals is emerging with the rise of resistance and immunocompromised patients. Continuous use of azole drugs, which act by inhibiting the fungal CYP51, invo...
Autores principales: | Teixeira, Melissa Martins, Carvalho, Diogo Teixeira, Sousa, Emília, Pinto, Eugénia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698508/ https://www.ncbi.nlm.nih.gov/pubmed/36422557 http://dx.doi.org/10.3390/ph15111427 |
Ejemplares similares
-
Antifungal Activity of a Library of Aminothioxanthones
por: Cardoso, Joana, et al.
Publicado: (2022) -
Lichen Xanthones as Models for New Antifungal Agents
por: Resende, Diana I. S. P., et al.
Publicado: (2018) -
In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis
por: de Macedo-Silva, Sara Teixeira, et al.
Publicado: (2013) -
Mycoremediation of azole antifungal agents using in vitro cultures of Lentinula edodes
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2019) -
Clinical analysis of the effects of azole antifungal agents on the anticoagulant activity of warfarin
por: Chen, Wenjun, et al.
Publicado: (2020)